PRLD peer analysis
PRLD (PRLD) against its competitors: price, today's move, 1-year return and market value side by side.
- PRLD's peers: AVTX (Avalo Therapeutics), CRBU (Caribou Biosciences), ENTA (Enanta Pharmaceuticals), EPRX (Eupraxia), FHTX (Foghorn Therapeutics), IMRX (Immuneering), IVA (Inventiva), OBIO (Orchestra BioMed).
PRLD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVTX Avalo Therapeutics | $6.76 | 0.15% | -61.57% | $390.88M |
| CRBU Caribou Biosciences | $0.30 | -4.86% | -83.77% | $31.91M |
| ENTA Enanta Pharmaceuticals | $7.62 | -4.51% | -37.18% | $221.94M |
| EPRX Eupraxia | $5.80 | -5.23% | -6.45% | $390.16M |
| FHTX Foghorn Therapeutics | $1.66 | -6.74% | -65.84% | $99.54M |
| IMRX Immuneering | $3.33 | -3.48% | -53.56% | $215.66M |
| IVA Inventiva | $3.18 | -7.84% | -23.01% | $165.28M |
| OBIO Orchestra BioMed | $6.58 | -6.00% | 41.20% | $517.88M |
| PYXS Pyxis Oncology | $1.81 | 7.74% | -60.39% | $216.49M |
| TNYA Tenaya Therapeutics | $0.29 | -1.54% | -75.30% | $66.99M |
| PRLD Prelude Therapeutics Incorporated | $3.22 | -1.08% | 92.81% | $257.83M |